SULLIVAN JOHN F (VP of Quality & Engineering) sold 44.3% of their position (8.60K shares) of TRANSMEDICS GROUP, INC. on the open market
Open‑market sale worth $282.2K — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 2/11/2021ACC: 0000899243-21-005847
Officer· VP of Quality & Engineering
Since May 2019
+8.60K
Net shares
Net buyer
$282.2K
Total sold
2
Open market trades
0B · 2S
4
Total transactions
17.20K acquired · 8.60K disposed
Non-Derivative Transactions3
Common Stock
Direct
Shares
+8.60K
Price / share
$0.28
Trade value
$2.41K
% of position
79.4%
2/9/2021
10.83K→19.43K
Common Stock
Direct
Shares
−8.40K
Price / share
$32.78
Trade value
$275.35K
% of position
43.2%
2/9/2021
19.43K→11.03K
Common Stock
Direct
Shares
−200.00
Price / share
$34.18
Trade value
$6.84K
% of position
1.8%
2/9/2021
11.03K→10.83K
Total
Net shares
+0.00
Net value
-$279.78K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/9/2021 | M · Option Exercise | +8.60K | $0.28 | $2.41K | 79.4% | 10.83K | 19.43K |
| Common Stock Direct | 2/9/2021 | S · Sale | −8.40K | $32.78 | $275.35K | 43.2% | 19.43K | 11.03K |
| Common Stock Direct | 2/9/2021 | S · Sale | −200.00 | $34.18 | $6.84K | 1.8% | 11.03K | 10.83K |
| Total | +0.00 | -$279.78K | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
8.60K shares
Shares
+8.60K
Strike price
0.28
Held after
0.00
Exercisable
—
2/9/2021
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock8.60K shares | 2/9/2021 | M · Option Exercise | +8.60K | 0.28 | — | 0.00 |